Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEMQA
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $160,743
Award facts
- Contract value 100% obligated
- $160,742.53 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $160,742.53 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued without set-aside designation on December 23, 2025, represents a task order under the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical supply support to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group holds a single-award Indefinite Delivery Contract under this program (contract SPE2DR, valued at $499.999 billion through December 31, 2036) and serves as one of multiple regional prime vendor contractors authorized to supply branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and medical consumables.
The contractor's product portfolio encompasses a broad range of pharmaceuticals critical to military medical operations, including oncology treatments, immunosuppressants, emergency medications, specialty surgical products, and routine pharmaceuticals. DMS Pharmaceutical Group demonstrates substantial contracting capability through consistent performance on numerous delivery orders issued by the DLA Medical Supply Chain division, with awards ranging from under $100 to over $115,000. No subcontractors are identified in this award documentation. The delivery order is scheduled for completion by December 24, 2025, with performance to be conducted at the contractor's Park Ridge, Illinois facility.
Quick answers
Who was awarded contract SPE2DU26FEMQA?
SPE2DU26FEMQA was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 23, 2025.
How much is contract SPE2DU26FEMQA worth?
The government has obligated $160,743 on SPE2DU26FEMQA.
Is contract SPE2DU26FEMQA an order under another contract?
Yes. SPE2DU26FEMQA is a delivery order under SPE2DU25D9517, an indefinite delivery contract.
Was contract SPE2DU26FEMQA competed?
The extent of competition for SPE2DU26FEMQA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award